Table 2. Known molecular target candidates for diagnosis and therapy of RA.
Category | Symbol | P Value | Chemical | RA association | Associated Modules |
PPI | PTPRC | <0.00001 | O | O | T cell activation |
JAK1 | <0.00001 | O | O | JAK-STAT signaling | |
CD19 | <0.00001 | O | O | B cell activation | |
TNF | <0.00001 | O | O | Inflammatory cytokines | |
CXCR4 | <0.00001 | O | O | Cell migration and adhesion, Chemokines | |
TLR4 | <0.00001 | O | O | Toll-like receptor signaling | |
CD247 | <0.00001 | O | O | T cell activation, NK cell mediated cytotoxicity | |
CCR3 | 0.00001 | O | O | Chemokines | |
THBS1 | 0.00027 | O | O | Matrix remodeling | |
TF | NFKB1 | <0.00001 | O | O | Matrix remodeling, NK cell mediated cytotoxicity, Cell death and survival, Chemokines |
TP53 | <0.00001 | O | O | Cell death and survival | |
JUN | 0.00001 | O | O | Matrix remodeling, ECM organization | |
FOXP3 | 0.00009 | O | O | T cell activation | |
POU2F1 | 0.00028 | O | O | B cell activation | |
ETS2 | 0.00377 | O | O | Angiogenic factors, Chemokines |